GSK plcGSKNYSE
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank28
Year-over-Year Change
Year-over-year free cash flow growth rate
Percentile
P28
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -43.21% |
| Q4 2025 | 77.66% |
| Q2 2025 | 109.90% |
| Q1 2025 | -41.62% |
| Q4 2024 | -8.99% |
| Q3 2024 | 95.53% |
| Q2 2024 | -23.41% |
| Q1 2024 | -71.10% |
| Q4 2023 | 76.75% |
| Q3 2023 | 122.15% |
| Q2 2023 | 262.18% |
| Q1 2023 | -138.38% |
| Q4 2022 | 10.52% |
| Q3 2022 | -7.18% |
| Q2 2022 | -38.69% |
| Q1 2022 | -53.03% |
| Q4 2021 | 31.48% |
| Q3 2021 | 180.90% |
| Q2 2021 | 5042.78% |
| Q1 2021 | -100.58% |
| Q4 2020 | 1754.60% |
| Q3 2020 | -90.97% |
| Q2 2020 | 279.71% |
| Q1 2020 | -76.90% |
| Q4 2019 | 30.74% |
| Q3 2019 | 172.68% |
| Q2 2019 | 110.03% |
| Q1 2019 | -89.70% |
| Q4 2018 | 111.66% |
| Q3 2018 | 66.77% |
| Q2 2018 | 94.29% |
| Q1 2018 | -76.81% |
| Q4 2017 | 56.39% |
| Q3 2017 | 253.79% |
| Q2 2017 | -45.60% |
| Q1 2017 | -67.35% |
| Q4 2016 | 75.31% |
| Q3 2016 | 67.59% |
| Q2 2016 | 754.31% |
| Q1 2016 | -114.09% |